Nautilus Biotechnology Inc Ordinary Shares NAUT
News
Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS Consortium
Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026
Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms
